Skip to content

Company information lookup

ACTINOGEN LIMITED (ACW)

Commercialisation of bioactive compounds

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
ACW 0.035 -12.5% 0.034 0.043 0.040 0.040 0.035 652,000
(Status - RE)

ACTINOGEN LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code ACW
Securities
Official Listing Date 16 October, 2007
GICS Industry Group Materials
Exempt Foreign? No
Internet Address http://www.actinogen.com.au
Registered Office Address Level 2, 1 Walker Avenue, WEST PERTH, WA, AUSTRALIA, 6005
Head Office Telephone +61 8 9481 3860
Head Office Fax +61 8 9321 1204
Share Registry AUTOMIC REGISTRY SERVICES
LEVEL 1, 7 VENTNOR AVENUE, WEST PERTH, WA, AUSTRALIA, 6005
Share Registry Telephone (08) 9324 2099
Directors / Senior Management
Mr Brendan De Kauwe (Executive Chairman)
Dr Jason Loveridge (Non Exec. Director)
Mr Daniel Parasiliti (Non Exec. Director)
Dr Anton Uvarov (Non Exec. Director)
Company Secretary Mr Peter Webse
Principal Activities Commercialisation of bioactive compounds

ACTINOGEN LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
19/11/2014   Results of Annual General Meeting 4 PDF
05/11/2014 asterix New Patents Allowed for B-HSD1 Inhibitor 2 PDF
23/10/2014 asterix Appendix 4C & Commentary 10 PDF
16/10/2014   Annual Report to shareholders 68 PDF
16/10/2014   Notice of Annual General Meeting/Proxy Form 82 PDF
12/09/2014   Appointment of Vice President of Clinical Research 1 PDF
03/09/2014   Change in Substantial Shareholding x 3 6 PDF
02/09/2014   Information Required under Asx Listing Rule 3.10.5A 1 PDF
02/09/2014   Section 708A Notice 1 PDF
02/09/2014   Appendix 3B -Share Placement 12 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
21 Nov 2014 0.035 -12.5% 0.040 0.035 652,000
20 Nov 2014 0.040 0% 0.045 0.040 1,030,000
19 Nov 2014 0.040 2.56% 0.040 0.037 270,000
18 Nov 2014 0.039 -2.5% 0.039 0.039 100,000
17 Nov 2014 0.040 0% 0.040 0.040 200,000

* Volume of shares shown represents only those shares traded on ASX.

ACTINOGEN LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security ACW. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security ACW

Warrants & Structured Products

No warrants & Structured Products are available over the security ACW